Public Calendar: March 22-28, 2020
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs
Event Date: 03/28/2020
Location: Teleconference
Subject: Lessons from the Front Lines: COVID-19
FDA Participant/Group: DAYLE CRISTINZIO; ANAND SHAH; DEBRA BIRNKRANT; JEFFREY MURRAY;
Non FDA Participant/Group: Industry, government, and academia
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
Event Date: 03/24/2020
Location: Virtual
Subject: The Role of Digital Health Technologies in Drug Development - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Academics, industry, government, and other stakeholders
Event Date: 03/24/2020
Location: Virtual
Subject: Wall Street Journal Annual Health Forum - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Media, academics, industry, patients, and other stakeholders
Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
No Significant Event
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event